Send high-impact biotech press alerts to trading analysts

You receive raw biotech press releases that bury regulatory or clinical catalysts and delay trading decisions. Benefit: prioritized, scored summaries arrive in your inbox within minutes for rapid review.

Overview

Missing regulatory or clinical headlines slows decision-making and leaves short-term moves unseen; this workflow surfaces and scores press releases and delivers concise summaries to analysts. The result: prioritized, evidence-focused email alerts to your inbox within minutes so teams can act ahead of market windows.